We are live on ! Find out more
CANY

Caxton Associates (New York) Portfolio holdings

AUM $3.18B
1-Year Est. Return 54.49%
This Fund
S&P 500
This Quarter Est. Return
+18.99%
1 Year Est. Return
+54.49%
3 Year Est. Return
+73.91%
5 Year Est. Return
+212.89%
10 Year Est. Return
+632.2%
AUM
$3.18B
AUM Growth
+$505M
Cap. Flow
+$202M
Cap. Flow %
6.35%
Top 10 Hldgs %
63.18%
Holding
711
New
199
Increased
99
Reduced
149
Closed
234

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$182M
2
TSLA icon
Tesla
TSLA
+$107M
3
CNC icon
Centene
CNC
+$68.7M
4
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$55.4M
5
ISRG icon
Intuitive Surgical
ISRG
+$52.1M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 46.05%
2 Technology 20.45%
3 Healthcare 7.37%
4 Financials 6.61%
5 Communication Services 5.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BIO icon
301
Bio-Rad Laboratories Class A
BIO
$8.19B
$590K 0.02%
+1,797
New +$610K
BURL icon
302
Burlington
BURL
$22.3B
$590K 0.02%
2,070
+637
+44% +$172K
BLND icon
303
Blend Labs
BLND
$419M
$584K 0.02%
138,669
+37,338
+37% +$161K
SHOO icon
304
Steven Madden
SHOO
$3.18B
$583K 0.02%
13,718
HIW icon
305
Highwoods Properties
HIW
$3.58B
$582K 0.02%
19,046
-4,787
-20% -$156K
PACB icon
306
Pacific Biosciences
PACB
$429M
$577K 0.02%
+315,348
New +$616K
MTZ icon
307
MasTec
MTZ
$28.2B
$575K 0.02%
+4,222
New +$566K
V icon
308
Visa
V
$672B
$570K 0.02%
1,804
-3,169
-64% -$953K
OSPN icon
309
OneSpan
OSPN
$562M
$557K 0.02%
30,058
+8,566
+40% +$146K
AZPN
310
DELISTED
Aspen Technology Inc
AZPN
$555K 0.02%
+2,223
New +$542K
MCD icon
311
McDonald's
MCD
$187B
$554K 0.02%
+1,910
New +$570K
NMRK icon
312
Newmark Group
NMRK
$2.72B
$550K 0.02%
42,974
-43,253
-50% -$639K
EGBN icon
313
Eagle Bancorp
EGBN
$822M
$547K 0.02%
21,002
-4,620
-18% -$124K
FBIN icon
314
Fortune Brands Innovations
FBIN
$5.99B
$544K 0.02%
7,958
+2,391
+43% +$192K
TEAM icon
315
Atlassian
TEAM
$21.7B
$542K 0.02%
+2,227
New +$510K
HRB icon
316
H&R Block
HRB
$5.01B
$542K 0.02%
10,253
-16,892
-62% -$993K
FIX icon
317
Comfort Systems
FIX
$63B
$540K 0.02%
+1,273
New +$559K
CORT icon
318
Corcept Therapeutics
CORT
$9.76B
$536K 0.02%
+10,632
New +$557K
INSM icon
319
Insmed
INSM
$23.1B
$530K 0.02%
7,678
-591
-7% -$42.6K
GILD icon
320
Gilead Sciences
GILD
$162B
$524K 0.02%
5,671
-11,929
-68% -$1.07M
VIR icon
321
Vir Biotechnology
VIR
$1.58B
$524K 0.02%
71,348
BCC icon
322
Boise Cascade
BCC
$2.73B
$522K 0.02%
+4,389
New +$606K
GWRE icon
323
Guidewire Software
GWRE
$11.2B
$520K 0.02%
+3,086
New +$576K
OLO
324
DELISTED
Olo Inc
OLO
$516K 0.02%
+67,239
New +$420K
LUMN icon
325
Lumen
LUMN
$6.9B
$513K 0.02%
+96,660
New +$667K

Similar funds

Caxton Associates (New York)'s Q4 2024 Portfolio in Review

As of Q4 2024, Caxton Associates (New York) held 711 positions worth $3.18B, up 19% from $2.67B the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Caxton Associates (New York) deployed $202M of net new capital in Q4 2024, opening 199 new positions and adding to 99 existing holdings. Its largest new stake was Centene: 1,101,163 shares worth $66.7M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 46% of assets, up from 32% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $36.8M trimmed.

  • Caxton Associates (New York)'s largest Q4 2024 buy was Centene: 1,101,163 shares worth $66.7M.
  • Caxton Associates (New York) added most to Amazon in Q4 2024, an estimated $182M increase.
  • Caxton Associates (New York)'s biggest Q4 2024 reduction was Meta Platforms (Facebook), cutting an estimated $36.8M.
  • Caxton Associates (New York) fully exited CATALENT, INC. in Q4 2024, selling an estimated $31.8M.
  • Caxton Associates (New York)'s ten largest holdings make up 63% of its $3.18B portfolio in Q4 2024.
  • Caxton Associates (New York) opened 199 new positions and closed 234 in Q4 2024.
  • Caxton Associates (New York)'s portfolio value rose 19% quarter-over-quarter to $3.18B.

Based on Caxton Associates (New York)'s 13F filing for Q4 2024, filed 14 Feb 2025.